Skip to main navigation Skip to search Skip to main content

Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice

  • Mark Veugelers
  • , David Wilkes
  • , Kimberly Burton
  • , Deborah A. McDermott
  • , Yan Song
  • , Marsha M. Goldstein
  • , Krista La Perle
  • , Carl J. Vaughan
  • , Art O'Hagan
  • , Kenneth R. Bennett
  • , Beat J. Meyer
  • , Eric Legius
  • , Mervi Karttunen
  • , Reijo Norio
  • , Helena Kaariainen
  • , Michael Lavyne
  • , Jean Philippe Neau
  • , Gert Richter
  • , Kaan Kirali
  • , Alan Farnsworth
  • Karen Stapleton, Peter Morelli, Yoshinori Takanashi, John Steven Bamforth, Franz Eitelberger, Irene Noszian, Waldimiro Manfroi, James Powers, Yoshihiko Mochizuki, Tsuneo Imai, Gary T.C. Ko, Deborah A. Driscoll, Elizabeth Goldmuntz, Jay M. Edelberg, Amanda Collins, Diana Eccles, Alan D. Irvine, G. Stanley McKnight, Craig T. Basson
  • Cornell University
  • University of Washington
  • OPKO Health, Inc.
  • Belfast Health and Social Care Trust
  • University of Mississippi
  • University of Bern
  • KU Leuven
  • Ilomantsin Terveyskeskus
  • Family Federation of Finland
  • University of Turku
  • CHU de Poitiers
  • Innere Medizin/Kardiologie
  • Kosuyolo Heart Hospital
  • Sydney Adventist Hospital
  • Yokohama City University
  • University of Alberta
  • Hospital of the Sisters of Mercy
  • Universidade Federal do Rio Grande do Sul
  • Rochester General Hospital
  • Dokkyo Medical University
  • Nagoya University
  • Alice Ho Miu Ling Nethersole Hospital
  • University of Pennsylvania
  • University Hospital Southampton NHS Foundation Trust
  • Children’s Health Ireland

Research output: Contribution to journalArticlepeer-review

144 Scopus citations

Abstract

Carney complex (CNC) is a familial multiple neoplasia syndrome characterized by cardiac and extracardiac myxomas in the setting of spotty skin pigmentation and endocrinopathy. We previously identified PRKAR1A (regulatory subunit 1α of protein kinase A) mutations in CNC. Mutational analyses of the PRKAR1A gene in 51 unrelated CNC probands now detect mutations in 65%. All mutations, except for one unique missense mutation, lead to PRKAR1A haploinsufficiency. Therefore, we studied the consequences of prkar1a haploinsufficiency in mice. Although we did not observe cardiac myxomas or altered pigmentation in prkar1a+/- mice, we did observe some phenotypes similar to CNC, including altered heart rate variability. Moreover, prkar1a+/- mice exhibited a marked propensity for extracardiac tumorigenesis. They developed sarcomas and hepatocellular carcinomas. Sarcomas were frequently associated with myxomatous differentiation. Tumors from prkar1a+/- mice did not exhibit prkar1a loss of heterozygosity. Thus, we conclude that although PRKAR1A haploinsufficiency does predispose to tumorigenesis, distinct secondary genetic events are required for tumor formation.

Original languageEnglish
Pages (from-to)14222-14227
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number39
DOIs
StatePublished - Sep 28 2004

Fingerprint

Dive into the research topics of 'Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice'. Together they form a unique fingerprint.

Cite this